Benidipine prevents oxidative stress, inflammatory changes and apoptosis related myofibril damage in isoproterenol-induced myocardial infarction in rats

Toxicology Mechanisms and Methods

Volumn 25, Issue 1, 2015, Pages 26-33

  Hassan, Md Quamrul ^a   Akhtar, Md Sayeed ^a   Akhtar, Mohd ^a   Ansari, Shahid Hussian ^b   Ali, Javed ^a   Haque, Syed Ehtaishamul ^a   Najmi, Abul Kalam ^a  

^a HAMDARD UNIVERSITY   (India)

^b Department of Pharmacognosy ^*  (Austria)

Author keywords

Apoptosis; Benidipine; C reactive protein; Cardiac biomarkers; Isoproterenol; Oxidative stress

Indexed keywords

ANTIOXIDANT; BENIDIPINE; C REACTIVE PROTEIN; CASPASE 3; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; ISOPRENALINE; LIPID PEROXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; ANTIINFLAMMATORY AGENT; AUTACOID; BIOLOGICAL MARKER; DIHYDROPYRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARDIOTOXICITY; CELL DAMAGE; CELL MEMBRANE; CONTROLLED STUDY; CYTOARCHITECTURE; DRUG EFFECT; HEART; HEART MUSCLE CELL; INFLAMMATION; INFLAMMATORY CELL; ISOPROTERENOL-INDUCED MYOCARDIAL INFARCTION; LIPID PEROXIDATION; MUSCLE FIBRIL; NONHUMAN; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; RAT; ANIMAL; BLOOD; CELL PROTECTION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; FEMALE; HEART MUSCLE; IMMUNOLOGY; MALE; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; TIME; ULTRASTRUCTURE; WISTAR RAT;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOPTOSIS; BIOLOGICAL MARKERS; BIOMARKERS; CYTOPROTECTION; DIHYDROPYRIDINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INFLAMMATION MEDIATORS; ISOPROTERENOL; LIPID PEROXIDATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOFIBRILS; OXIDATIVE STRESS; RATS, WISTAR; TIME FACTORS;

EID: 84919424856     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2014.972531     Document Type: Article

References (47)

1. Carlberg I, Mannerviek B. (1975). Glutathione reductase levels in rat brain. J Biol Chem 250:5475-80.
2. Claiborne A. (1985). Catalase activity. In Greenwald RA, ed. Handbook of methods for oxygen free radical research. Boca Raton: CRC Press, 283-4.
3. Critchley BJA, Capewell S. (2004). Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 109:1101-7.
4. Dhalla NS, Adameova A, Kaur M. (2010). Role of catecholamine oxidation in sudden cardiac death. Fund Clin Pharmacol 24:539-46.
5. Dhalla NS, Dent MR, Arneja AS. (2008). Pathogenesis of catecholamine-induced cardiomyopathy. In Acosta Jr D, ed. Cardiovascular toxicology, 4th ed. New York: Informa Healthcare USA Inc., 207-62.
6. Dhalla NS, Temsah RM, Netticadan T. (2000). Role of oxidation stress in cardiovascular disease. J Hypertension 31:152-61.
7. Eckersall PD. (2000). Recent advances and future prospects for the use of acute phase proteins and markers of disease in animals. Rev Med Vet 151:577-84.
8. Ferrari R, Ceconi CS, Curello C, et al. (1985). Oxygen mediated myocardial damage during ischemia and reperfusion; role of cellular defenses against oxygen toxicity. J Mol Cell Cardiol 17:937-45.
9. Fridovich I. (1978). The biology of oxygen radicals. Science 201: 875-80.
10. Gurtu V, Kain SR, Zhang G. (1997). Fluorometric and colorimetric detection of caspase activity associated with apoptosis. Anal Biochem 251:98-102.
11. Habig WH, Pabst MJ, Jakoby WB. (1974). Glutathione S-transferases: the first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130-9.
12. Ishii A, Nishida K, Oka T, Nakamizo N. (1988). Slow dissociation of the new slow-onset and long-acting calcium antagonist benidipine hydrochloride from 3H-nitrendipine binding sites. Arzneimittelforschung 38:1681-3.
13. Ishii A, Toyama J. (1993). Binding properties of (+/-)[3H]benidipine hydrochloride to rat heart membranes. J Cardiovasc Pharmacol 2: 191-6.
14. Kellog EW, Fridovich I. (1975). Superoxide, hydrogen peroxide, and singlet oxygen in lipid peroxidation by a xanthine oxidase system. J Biol Chem 250:8812-17.
15. Kuulasmaa K, Tunstall PH, Dobson AJ, et al. (2000). Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA project. Lancet 355:675-87.
16. Liu HR, Gao F, Tao L, et al. (2004). Antiapoptotic mechanisms of benidipine in the ischemic/reperfused heart. Br J Pharmacol 142: 627-34.
17. Lowry OH, Rosebrough NH, Farr AL, Randall RJ. (1951). Protein measurements with the Folin phenol reagent. J Biol Chem 193: 265-75.
18. Lum G, Gambino SR. (1974). A comparison of serum vs heparinised plasma for routine chemistry tests. Am J Clin Pathol 61:108-13.
19. Marklund S, Marklund G. (1974). Involvement of superoxide anion radical in auto oxidation by pyrogallol and a convenient assay of superoxide dismutase. Eur J Biochem 47:469-74.
20. Matsubara M, Akizuki O, Ikeda J, et al. (2008). Benidipine, an antihypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats. Eur J Pharmacol 580: 201-13.
21. Matsubara M, Hasegawa K. (2005). Benidipine, a dihydropyridinecalcium channel blocker, prevents lysophosphatidylcholine-induced injury and reactive oxygen species production in human aortic endothelial cells. Atherosclerosis 178:57-66.
22. Matsubara M, Yao K, Hasegawa K. (2006). Benidipine, a dihydropyridine-calcium channel blocker, inhibits lysophosphatidylcholineinduced endothelial injury via stimulation of nitric oxide release. Pharmacol Res 53:35-43.
23. Okhawa H, Ohishi N, Yagi K. (1970). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 34:30-8.
24. Ostadal B, Pelouch V, Ostadalova I, et al. (1995). Structural and biochemical remodeling in catecholamine-induced cardiomyopathy: comparative and ontogenetic aspects. Mol Cell Biochem 147:83-8.
25. Pogodina LS, Shornikova MV, Chentsov IS. (2006). Electron microscopy description of cardiomyocytes from the left ventricle of rat heart after apoptosis induction by isoproterenol. Izvestiia Akademii nauk. Seriia Biologicheskaia/Rossiiskaia Akademiia Nauk 1:26-37.
26. Rathore N, John S, Kale M, Bhatnagar D. (1998). Lipid peroxidation and antioxidant enzymes in isoproterenol induced oxidative stress in rat tissues. Pharmacol Res 38:297-303.
27. Remondino A, Kwon SH, Communal C, et al. (2003). b-Adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res 92:136-8.
28. Ridker PM, Hennekens CH, Buring JE, Rifai N. (2000). C-reactive proteinand other markers of inflammation in the prediction of cardiovascular disease in women. New Engl J Med 342:836-43.
29. Rona G. (1985). Catecholamine cardiotoxicity. J Mol Cell Cardiol 17: 291-306.
30. Rona G, Boutet M, Jttner L, Peters H. (1975). Pathogenesis of isoproterenol-induced myocardial alterations. Functional and morphological correlates. In Dhalla N, ed. Recent advances in studies on cardiac structure and metabolism. Myocardial metabolism, Vol 3. Baltimore: University Park Press, 507-25.
31. Rona G, Chappel CI, Balazs T, Gaudry R. (1959a). An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch Pathol 167:443-55.
32. Rona G, Ttner I, Boutet M. (1977). Microcirculatory changes in myocardium with particular reference to catecholamine-induced cardiac muscle cell injury. In Meesen H, ed. Handbuch der allgemeinen pathologie iii/7, mikrozirkulafion/microcirculation. Berlin, Heidelberg, New York: Springer, 791-888.
33. Rona G, Zsoter R, Chappel CI, Gaudry R. (1959b). Myocardial lesions, circulatory and electrocardiographic changes produced by isoproterenol in the dog. Rev Canad Biol 18:83-94.
34. Sabeena FKH, Anandan R, Kumar SH, et al. (2004). Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats. Pharmacol Res 50:231-6.
35. Scott MD, Lubin BH, Zuo L, et al. (1991). Erythrocyte defense against hydrogen peroxide, preeminent importance of catalase. J Lab Clin Med 118:7-16.
36. Searle AJ, Wilson RL. (1980). Glutathione peroxidase: effect of superoxide, hydroxyl and bromine free radicals on enzyme activity. Intl J Radiat Biol Relat Stud Phys Chem Med 37:213-17.
37. Sedlak J, Lindsay RH. (1968). Estimation of total protein bound and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 25:192-205.
38. Suzuki O, Yoshida T, Tani S, et al. (2004). Antioxidative effects of benidipine hydrochloride in patients with hypertension independent of antihypertensive effects. Relationship between blood pressure and oxidative stress. Arzneimittelforschung 54:505-12.
39. Takeo S, Taam BML, Beamsh RE, Dhalla NS. (1981). Effect of adrenochrome on calcium accumulation by heart mitochondria. Biochem Pharmacol 30:157-63.
40. Ueda S, Ikeda U, Yamamoto K. (1996). C-reactive protein as a predictor of cardiac rupture after acute myocardial infarction. Am Heart J 131: 857-60.
41. Wang S, Tian S, Yang F, et al. (2009). Cardioprotective effect of salvianolic acid A on isoproterenol-induced myocardial. Eur J Pharmacol 615:125-32.
42. Wheeler R, Jhaine AS, Elsayeed MN, et al. (1990). Automated assays for superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase activity. Anal Biochem 184:193-9.
43. Yao K, Ina Y, Sonoda R, et al. (2003). Protective effects of benidipine on hydrogen peroxide-induced injury in rat isolated hearts. J Pharm Pharmacol 55:109-14.
44. Yao K, Nagashima K, Miki H. (2006). Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker. J Pharmacol Sci 100: 243-61.
45. Yasunari K, Maeda K, Nakamura M, et al. (2005). Benidipine, a longacting calcium channel blocker, inhibits oxidative stress in polymorphonuclear cells in patients with essential hypertension. Hypertens Res 28:107-12.
46. Yates JC, Beamish RE, Dhalla NS. (1981). Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: relation to pathogenesis of catecholamine cardiomyopathy. Am Heart J 1112:210-21.
47. Young DS. (1990). Effects of drugs on clinical laboratory tests. Washington: American Association of Clinical Chemistry Press.